Anivive Logo
Valley FeverFIPTreatmentsSearchLight DNAPathologyTrialsEngage
  • Valley Fever
    What is Coccidioides
    Health Impacts
    Where is Valley Fever
    Gronk
    Resources
  • FIP
  • Treatments
    Biologics
    Discovery
  • SearchLight DNA
    Clinical Benefit
    Data Facts
    Success Stories
    For Pet Owners
    Resources
  • Pathology
  • Trials
  • Engage
  • Events
  • Learn
  • About
    Investor Relations
    Company Profile
    Leadership and Governance
    Social Responsibility
    Investor FAQ
    Contact

Dr. John Chretin

Technical Paper

Prophylactic trimethoprim-sulfadiazine during chemotherapy in dogs with lymphoma and osteosarcoma: a double-blind, placebo-controlled study

Dr. John Chretin
Technical Paper

Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs

Dr. John Chretin
Technical Paper

Phase 1 Dose-Escalation Study with LEC/chTNT-3 and Toceranib Phosphate (Palladia(®)) in Dogs with Spontaneous Malignancies

David Bruyette, DVM
Dr. John Chretin
Technical Paper

Acquired factor V inhibitors after allogeneic hematopoietic stem cell transplantation in a dog

Dr. John Chretin
Technical Paper

Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs

Dr. John Chretin
Technical Paper

Phase I dose escalation of single-agent vinblastine in dogs

Dr. John Chretin
CONTACT US

1-833-ANIVIVE

At Anivive, we are more than a pet pharmaceutical company.
Our innovations and discoveries bring lasting hope to families in need.
LOCATION

3777 Worsham Ave, Suite 200

Long Beach, CA 90808

United States

LATEST POSTS
Anivive LogoCopyright 2025 © Anivive
All rights reserved
Terms of Service
Privacy Policy